Mark Iwicki
2018
In 2018, Mark Iwicki earned a total compensation of $3.1M as Chief Executive Officer at Kala Pharmaceuticals, a 65% increase compared to previous year.
Compensation breakdown
| Bonus | $385,000 |
|---|---|
| Option Awards | $2,144,795 |
| Salary | $534,681 |
| Other | $7,709 |
| Total | $3,072,185 |
Iwicki received $2.1M in option awards, accounting for 70% of the total pay in 2018.
Iwicki also received $385K in bonus, $534.7K in salary and $7.7K in other compensation.
Rankings
In 2018, Mark Iwicki's compensation ranked 3,780th out of 14,244 executives tracked by ExecPay. In other words, Iwicki earned more than 73.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,780 out of 14,244 | 74th |
Division Manufacturing | 1,399 out of 5,759 | 76th |
Major group Chemicals And Allied Products | 496 out of 2,122 | 77th |
Industry group Drugs | 413 out of 1,811 | 77th |
Industry Pharmaceutical Preparations | 321 out of 1,385 | 77th |
Source: SEC filing on April 12, 2019.
Iwicki's colleagues
We found two more compensation records of executives who worked with Mark Iwicki at Kala Pharmaceuticals in 2018.